Terminated PHASE3 INTERVENTIONAL 2-arm NCT01200589

Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy (HOMER)

Phase III Randomized, Open Label Study of Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy

Sponsor: GlaxoSmithKline

Conditions Non-Hodgkin's Lymphoma

Interventions Ofatumumab Rituximab

Updated 7 times since 2017 Last updated: Apr 16, 2018 Started: Oct 11, 2010 Primary completion: Dec 19, 2016 Completion: Dec 19, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study stopped due to futility.

Other terminated trials from GlaxoSmithKline

See all terminations from GlaxoSmithKline

A PHASE3 clinical study on Non-Hodgkin's Lymphoma, this trial is terminated or withdrawn. The trial is conducted by GlaxoSmithKline and has accumulated 7 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

Status: Completed → Terminated

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline
Novartis Pharmaceuticals

Data source: Novartis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aichi, Japan , Albuquerque, United States , Ames, United States , Anchorage, United States , Anderson, United States , Antwerp, Belgium , Athlone Park, Amanzimtoti, South Africa , Barretos, Brazil , Beijing, China , Betim, Brazil and 122 more locations